Your browser doesn't support javascript.
loading
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
Jongo, Said A; Church, L W Preston; Mtoro, Ali T; Schindler, Tobias; Chakravarty, Sumana; Ruben, Adam J; Swanson, Phillip A; Kassim, Kamaka R; Mpina, Maximillian; Tumbo, Anneth-Mwasi; Milando, Florence A; Qassim, Munira; Juma, Omar A; Bakari, Bakari M; Simon, Beatus; James, Eric R; Abebe, Yonas; Kc, Natasha; Saverino, Elizabeth; Fink, Martina; Cosi, Glenda; Gondwe, Linda; Studer, Fabian; Styers, David; Seder, Robert A; Schindler, Tobias; Billingsley, Peter F; Daubenberger, Claudia; Sim, B Kim Lee; Tanner, Marcel; Richie, Thomas L; Abdulla, Salim; Hoffman, Stephen L.
Affiliation
  • Jongo SA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Church LWP; Sanaria Inc., Rockville, Maryland, USA.
  • Mtoro AT; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Schindler T; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Chakravarty S; University of Basel, Switzerland.
  • Ruben AJ; Sanaria Inc., Rockville, Maryland, USA.
  • Swanson PA; Sanaria Inc., Rockville, Maryland, USA.
  • Kassim KR; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Mpina M; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Tumbo AM; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Milando FA; University of Basel, Switzerland.
  • Qassim M; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Juma OA; University of Basel, Switzerland.
  • Bakari BM; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Simon B; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • James ER; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Abebe Y; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Kc N; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania.
  • Saverino E; Sanaria Inc., Rockville, Maryland, USA.
  • Fink M; Sanaria Inc., Rockville, Maryland, USA.
  • Cosi G; Sanaria Inc., Rockville, Maryland, USA.
  • Gondwe L; Sanaria Inc., Rockville, Maryland, USA.
  • Studer F; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Styers D; University of Basel, Switzerland.
  • Seder RA; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Schindler T; University of Basel, Switzerland.
  • Billingsley PF; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Daubenberger C; University of Basel, Switzerland.
  • Sim BKL; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Tanner M; University of Basel, Switzerland.
  • Richie TL; The Emmes Corporation, Rockville, Maryland, USA.
  • Abdulla S; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hoffman SL; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Clin Infect Dis ; 71(11): 2849-2857, 2020 12 31.
Article in En | MEDLINE | ID: mdl-31782768

Full text: 1 Database: MEDLINE Main subject: Malaria, Falciparum / Malaria Vaccines / Malaria Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Animals / Humans Country/Region as subject: Africa / Europa Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Malaria, Falciparum / Malaria Vaccines / Malaria Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Animals / Humans Country/Region as subject: Africa / Europa Language: En Year: 2020 Type: Article